Bladder Cancer Imaging surgical Treatment pathology Management follow-up radiation Therapy systemic Therapy

5-alpha Reductase Inhibitors Adrenergic alpha-Antagonists Age Factors Humans Male Prostatic Hyperplasia/complications/physiopathology Time Factors Treatment Failure Treatment Outcome Urinary Bladder Underactive/complications/*physiopathology Urinary Retention/etiology/*physiopathology Benign prostatic enlargement Benign prostatic hyperplasia Bladder outlet obstruction Delayed prostatectomy Lower urinary tract symptoms

Animals Humans *Lower Urinary Tract Symptoms/drug therapy Male Prostatic Hyperplasia/therapy Urinary Bladder Overactive/complications *Urothelium/physiopathology

Ejaculation/physiology Humans Lower Urinary Tract Symptoms/etiology/physiopathology/therapy Male Minimally Invasive Surgical Procedures Prostatic Hyperplasia/complications/physiopathology/surgery/*therapy Randomized Controlled Trials as Topic Sexual Dysfunction Physiological/etiology Aquablation Benign prostatic hyperplasia Ejaculatory dysfunction Prostate artery embolization Prostatic urethral lift Water vapor thermal therapy

Humans Male Prostatic Hyperplasia/diagnostic imaging/pathology Randomized Controlled Trials as Topic Urologic Surgical Procedures Male

Adrenergic alpha-Antagonists/*administration & dosage/pharmacology Drug Interactions Drug Therapy Combination Erectile Dysfunction/complications/*drug therapy/physiopathology Hemodynamics/*drug effects Humans Lower Urinary Tract Symptoms/complications/*drug therapy/physiopathology Male Phosphodiesterase 5 Inhibitors/*administration & dosage/pharmacology Prostatic Hyperplasia/complications/*drug therapy/physiopathology Randomized Controlled Trials as Topic Alpha blocker Benign prostatic hyperplasia Erectile dysfunction Hemodynamic interaction Luts Phosphodiesterase-5 inhibitors

Bladder Cancer Molecular Pathology Guideline

Bladder Cancer Molecular Pathology Guideline

Aged Catheterization Humans *Laser Therapy Lower Urinary Tract Symptoms/physiopathology Male Prostate/physiopathology Prostatic Hyperplasia/physiopathology Randomized Controlled Trials as Topic *Transurethral Resection of Prostate Treatment Outcome benign prostatic hyperplasia (BPH) button-type bipolar plasma vaporization (BTPV) lower urinary tract symptoms (LUTS) transurethral resection (TURP)

Aged Humans Lower Urinary Tract Symptoms/*etiology Male Prostatic Hyperplasia Transurethral Resection of Prostate Urethra/physiopathology

Embolization Therapeutic Humans Male Prostate/*blood supply/pathology Prostatic Hyperplasia/diagnosis/*therapy Transurethral Resection of Prostate Treatment Outcome Benign prostatic hyperplasia Meta-analysis Prostatic artery embolization Transurethral resection of the prostate PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER’S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Aged Aged 80 and over Ejaculation Humans Lower Urinary Tract Symptoms/etiology Male Middle Aged Organ Size Penile Erection Prostate/pathology Prostatic Hyperplasia/complications Quality of Life Retreatment/statistics & numerical data Robotic Surgical Procedures Surgery Computer-Assisted/methods Transurethral Resection of Prostate *Water

Androgen Antagonists/*pharmacology Biomarkers/urine Humans Inflammation/urine Lower Urinary Tract Symptoms/physiopathology Male Observational Studies as Topic Phytotherapy Plant Extracts/*pharmacology Prostatic Hyperplasia/physiopathology/urine Randomized Controlled Trials as Topic Serenoa Treatment Outcome * Serenoa repens *Luts/bph *Permixon *hexanic extract *meta-analysis *systematic review

Humans Length of Stay Male Perioperative Period Prostate/pathology Prostatic Hyperplasia/epidemiology/pathology Randomized Controlled Trials as Topic Saline Solution Transurethral Resection of Prostate/*adverse effects/*economics/standards Treatment Outcome United Kingdom/epidemiology Urethral Stricture/complications Urologic Surgical Procedures *Bph *Benign prostate enlargement *Benign prostate hyperplasia *Cost minimisation analysis *Meta-analysis *TUR syndrome *Turp *TURis *Transurethral resection in saline *Transurethral resection of the prostate

Humans Laser Therapy Male Patient Selection Preoperative Period Prostatic Hyperplasia/complications/physiopathology *Quality of Life Transurethral Resection of Prostate/*adverse effects/methods Treatment Outcome Urinary Bladder Underactive/etiology/*physiopathology *Urodynamics *muscle hypertonia *prostate *prostatic hyperplasia *urethra

*Ejaculation Humans Male Prostatic Hyperplasia/complications Prostatism/etiology Randomized Controlled Trials as Topic Sexual Dysfunction Physiological/*etiology/physiopathology Urologic Surgical Procedures Male/*adverse effects benign prostatic hyperplasia decreased ejaculation ejaculatory dysfunction lower urinary tract symptoms painful ejaculation retrograde ejaculation

Embolization Therapeutic Humans Lower Urinary Tract Symptoms/*therapy Male Prostate/*blood supply Prostatic Hyperplasia/physiopathology/*therapy benign prostatic hyperplasia lower urinary tract symptoms meta-analysis prostate artery embolization

Disease Progression Humans Kallikreins/blood Male Metabolic Syndrome Organ Size Prostate/growth & development/pathology/physiopathology Prostate-Specific Antigen/blood Prostatic Hyperplasia/pathology/physiopathology

Humans Female *Urinary Bladder Neoplasms/pathology *Carcinoma Transitional Cell/pathology Urinary Bladder/pathology Prognosis Proportional Hazards Models Meta-analysis Muscle-invasive bladder urothelial carcinoma Non-muscle-invasive bladder urothelial carcinoma Sex

Humans *Carcinoma Transitional Cell/drug therapy *Urinary Bladder Neoplasms/pathology *Urologic Neoplasms/drug therapy/pathology Antibodies Monoclonal/adverse effects